{"schema_version":"secwatch.filing_event.v1","accession":"0000070318-23-000006","form_type":"8-K","ticker":"THC","cik":"0000070318","company_name":"TENET HEALTHCARE CORP","filed_at":"2023-02-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.805710+00:00","generated_at":"2026-06-19T21:07:11.887905+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Tenet Q4 net income $102M ($0.92 diluted EPS), FY2023 Adj. EBITDA guidance $3.16B-$3.36B","bullets":["Q4 2022 net income from continuing ops $102M ($0.92 diluted EPS) vs $250M ($2.30) a year ago; adjusted diluted EPS $1.96 vs $2.70.","Consolidated Q4 Adj. EBITDA $897M (incl $40M grant income) vs $1.017B; Ambulatory Adj. EBITDA ex-grant grew 18.7% to $407M.","FY2023 outlook: Adj. EBITDA $3.16B-$3.36B, adjusted diluted EPS $4.68-$5.85; net operating revenues $19.7B-$20.1B.","Repurchased 5.9M shares for $250M in Q4; entered deal to sell San Ramon Regional Medical Center for $142.5M (close expected 2023)."],"urls":{"canonical":"https://secwatch.observer/filing/0000070318-23-000006","json":"https://secwatch.observer/filing/0000070318-23-000006.json","markdown":"https://secwatch.observer/filing/0000070318-23-000006.md","text":"https://secwatch.observer/filing/0000070318-23-000006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/70318/000007031823000006/0000070318-23-000006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/70318/000007031823000006/thc-20230209.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T21:07:11.887905+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4023ce421cef50437a75fab555ca1143edfdecb4","claim":"TENET HEALTHCARE CORP reported quarter ended December 31, 2022 results: revenue $4,990, net income $102 million, EPS $0.92 per diluted share.","evidence_excerpt":"2021 are as follows: Three Months Ended December 31, Twelve Months Ended December 31, ($ in millions, except per share results) 2022 2021 2022 2021 Net operating revenues $4,990 $4,856 $19,174 $19,485 Net income available to Tenet common shareholders from continuing operations $102 $250 $410 $915 Net income available to Tenet common shareholders from","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031823000006/0000070318-23-000006-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"quarter ended December 31, 2022"},{"label":"Revenue","value":"$4,990"},{"label":"Net income","value":"$102 million"},{"label":"EPS","value":"$0.92 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}